EUVIMEDEUVIMED entdecken
Leitlinie

2024 Update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis: Secondary publication

Masayoshi Harigai iD, Yuko Kaneko iD, Eiichi Tanaka iD, Shintaro Hirata iD, Hideto Kameda iD, Kayoko Kaneko iD, Mitsumasa Kishimoto iD, Masataka Kohno, Masayo Kojima, Toshihisa Kojima iD, Akio Morinobu, Ayako Nakajima und 5 weitere

Modern Rheumatology · 08.04.2025 · 35 (3) · 387-401

DOI: 10.1093/mr/roaf006 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Modern Rheumatology, online erschienen am 17.01.2025. Verfasst von Masayoshi Harigai und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Rheumatoid. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 144 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this study is to update the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis (CPG for RA).

Methods

The recommendations were developed based on the evidence published until the end of June 2022 using the Grading of Recommendations Assessment, Development, and Evaluation. The steering committee, CPG panel, systematic review (SR) group, and SR support team were organised.

Results

The treatment goal and drug treatment algorithm required no modifications; however, the footnotes of the drug treatment algorithm were modified. SR of 21 new or updated recommendations for subcutaneous methotrexate (n = 1), biological disease-modifying antirheumatic drugs (n = 1), rituximab (n = 5), Janus kinase inhibitors (n = 6), biosimilars (n = 2), older patients (n = 4), and pregnancy and lactation (n = 2) was conducted. The recommendations for comorbidities and surgery and rehabilitation remained unchanged from the 2020 CPG for RA.

Conclusions

The 2024 CPG for RA, which provide recommendations that reflect the current healthcare environment for rheumatoid arthritis in Japan, can be used effectively as a tool for shared decision-making between rheumatologists and patients in the treatment of RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antirheumatic AgentsArthritis, RheumatoidHumansJapanRheumatology

Stichwörter der Autor:innen

GuidelinesJanus kinase inhibitorbiological disease-modifying antirheumatic drugmethotrexaterheumatoid arthritis

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.
  • Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University (Ohashi Medical Center), Meguro-ku, Tokyo, Japan.
  • Division of Maternal medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan.
  • Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.

ORCID-Profile: Masayoshi Harigai, Yuko Kaneko, Eiichi Tanaka, Shintaro Hirata, Hideto Kameda, Kayoko Kaneko, Mitsumasa Kishimoto, Toshihisa Kojima, Takahiko Sugihara, Mie Fusama, Nobuyuki Yajima, Yutaka Kawahito

Zitieren

APA

Harigai, M., Kaneko, Y., Tanaka, E., Hirata, S., Kameda, H., Kaneko, K., Kishimoto, M., Kohno, M., Kojima, M., Kojima, T., Morinobu, A., Nakajima, A., Sugihara, T., Fusama, M., Yajima, N., Yanai, R., & Kawahito, Y. (2025). 2024 Update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis: Secondary publication. Modern Rheumatology, 35(3), 387-401. https://doi.org/10.1093/mr/roaf006

Vancouver

Harigai M, Kaneko Y, Tanaka E, Hirata S, Kameda H, Kaneko K, et al. 2024 Update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis: Secondary publication. Modern Rheumatology. 2025;35(3):387-401. doi:10.1093/mr/roaf006

BibTeX
@article{Harigai2025,
  author = {Harigai, Masayoshi and Kaneko, Yuko and Tanaka, Eiichi and Hirata, Shintaro and Kameda, Hideto and Kaneko, Kayoko and Kishimoto, Mitsumasa and Kohno, Masataka and Kojima, Masayo and Kojima, Toshihisa and Morinobu, Akio and Nakajima, Ayako and Sugihara, Takahiko and Fusama, Mie and Yajima, Nobuyuki and Yanai, Ryo and Kawahito, Yutaka},
  title = {2024 Update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis: Secondary publication},
  journal = {Modern Rheumatology},
  year = {2025},
  volume = {35},
  number = {3},
  pages = {387--401},
  doi = {10.1093/mr/roaf006}
}
Kostenlos starten →